Central hypothyroidism in an infant born to an adequately treated mother with Graves' disease: an effect of maternally derived thyrotrophin receptor antibodies?
Zwaveling-Soonawala
Nitash
N
van Trotsenburg
Paul
P
Vulsma
Thomas
T
D000328:Adult; D013956:Antithyroid Agents / Q000009:adverse effects / Q000627:therapeutic use; D001323:Autoantibodies / Q000494:pharmacology*; D003409:Congenital Hypothyroidism / Q000209:etiology*; D005260:Female; D006111:Graves Disease / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011441:Propylthiouracil / Q000009:adverse effects / Q000627:therapeutic use; D011989:Receptors, Thyrotropin / Q000276:immunology*; D013974:Thyroxine / Q000627:therapeutic use
D013956:Antithyroid Agents; D001323:Autoantibodies; D011989:Receptors, Thyrotropin; D011441:Propylthiouracil; D013974:Thyroxine